Filter
826
Filtered Results: 826
Text search:
American
Heart
Association
Featured
Recommendations
81
New Publications
140
Language
Document type
No document type
401
Studies & Reports
197
Guidelines
113
Manuals
59
Strategic & Response Plan
20
Training Material
15
Fact sheets
13
Situation Updates
3
Resource Platforms
2
Infographics
2
App
1
Countries / Regions
Global
47
India
32
Latin America and the Carribbean
23
Philippines
21
Western and Central Europe
12
Russia
12
Syria
11
Indonesia
11
Brazil
11
Ethiopia
10
Kenya
10
USA
8
Africa
8
Ghana
7
Uganda
7
South Africa
7
Asia
6
Eastern Europe
6
Sierra Leone
5
Nepal
5
Zambia
5
Bangladesh
5
Ukraine
5
Guinea
4
Liberia
4
Tanzania
4
Malawi
4
Eswatini/ Swaziland
4
Colombia
4
Myanmar / Burma
4
Venezuela
4
North America
4
Congo, Democratic Republic of
3
Haiti
3
Mozambique
3
Namibia
3
Yemen
3
East and Southern Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Nigeria
2
Zimbabwe
2
South Sudan
2
Lebanon
2
Cambodia
2
Chile
2
West and Central Africa
2
Kyrgyzstan
2
Vietnam
2
Spain
2
Guinea-Bissau
1
Cameroon
1
Germany
1
Egypt
1
China
1
Ireland
1
Sudan
1
Argentina
1
Peru
1
Serbia
1
Croatia
1
Ecuador
1
Botswana
1
El Salvador
1
Bolivia
1
Angola
1
Lesotho
1
Sri Lanka
1
Other region
1
Paraguay
1
Laos
1
Canada
1
Tajikistan
1
Lithuania
1
Iran
1
Turkmenistan
1
Jamaica
1
Japan
1
United Kingdom
1
Portugal
1
Azerbaijan
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
187
Clinical Guidelines
122
Public Health
90
Women & Child Health
50
Key Resources
22
Capacity Building
17
Pharmacy & Technologies
5
Annual Report MEDBOX
1
General Guidelines
1
Toolboxes
Mental Health
152
NCDs
91
COVID-19
66
Planetary Health
45
Caregiver
39
Disability
32
Global Health Education
29
NTDs
27
Rapid Response
20
HIV
17
Social Ethics
17
Conflict
13
Refugee
12
Pharmacy
12
Ebola
10
Natural Hazards
10
AMR
8
Zika
6
TB
6
Cholera
3
Specific Hazards
3
Health Financing Toolbox
3
Polio
1
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...
Attention-Deficit/Hyperactivity Disorder
The ANA (American Nurses Association) is a internet platform, where you can find important resources about nursing care, work environment, advocacy, scope of practice and much more. ANA believes tha...
This Cardiac Rehabilitation Change Package was completed by the Centers for Disease Control and Prevention (CDC) in collaboration with the American Association of Cardiovascular and Pulmonary Rehabi...
This 400 page guide, created by PHI’s Center for Climate Change and Health and the American Public Health Association (APHA), with support from the California Department of Public Health helps loc...
Health in All Policies: A Guide for State and Local Governments was created by the Public Health Institute, the California Department of Public Health, and the American Public Health Association in...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and pr...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the ...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retriev...
This paper showed a large positive correlation coefficient between psychosocial health problems and dysfunctional abilities among rural community members
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for h... failure (HF). Moreover, HF patients with DM have a worse prognosis than those without DM. Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyperglycemia, hyperinsulinemia, and insulin resistance can cause alterations in vascular homeostasis. Then, reduced nitric oxide and increased reactive oxygen species levels favor inflammation leading to atherothrombotic progression and myocardial dysfunction. The classification, diagnosis, and treatment of HF for a patient with and without DM remain the same. Until now, drugs targeting neurohumoral and metabolic pathways improved mortality and morbidity in HF with reduced ejection fraction (HFrEF). Therefore, all HFrEF patients should receive guideline-directed medical therapy. By contrast, drugs modulating neurohumoral activity did not improve survival in HF with preserved ejection fraction (HFpEF) patients. Trials investigating whether sodium-glucose cotransporter-2 inhibitors are effective in HFpEF are on-going. This review will summarize the epidemiology, pathophysiology, and treatment of HF in diabetes.
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly gre...
